Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Cultured media from adipose derived stem cells promote corneal epithelial wound healing via increased cell proliferation and DNA metabolic process
Author Affiliations & Notes
  • MAKO OKAMOTO
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Yuichi Okumura
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine,, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Takenori Inomata
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine,, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Maria Miura
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Keiichi Fujimoto
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Kunihiko Hirosawa
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Ken Nagino
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
    Department of Digital Medicine,, Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • yuki moroka
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Fumihiro Hara
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Shintaro Nakao
    Juntendo Daigaku, Bunkyo-ku, Tokyo, Japan
  • Footnotes
    Commercial Relationships   MAKO OKAMOTO None; Yuichi Okumura InnoJin, Inc, Code E (Employment), Johnson & Johnson., FUKOKU Co., Ltd, Code F (Financial Support), InnoJin, Inc, Code P (Patent); Takenori Inomata Santen Pharmaceutical Co., Ltd, Code C (Consultant/Contractor), InnoJin, Inc., Code E (Employment), : Novartis Pharma KK, Santen Pharmaceutical Co., Ltd., Lion Corporation, SEED Co., Ltd., Johnson & Johnson, Shin Nippon Biomedical Laboratories, Ltd., IBM Japan, Ltd.; , Code F (Financial Support), Renatech Co., Ltd., InnoJin Inc, Code P (Patent); Maria Miura None; Keiichi Fujimoto None; Kunihiko Hirosawa Johnson & Johnson, Code F (Financial Support); Ken Nagino InnoJin Inc, Code E (Employment); yuki moroka Johnson & Johnson, Code F (Financial Support); Fumihiro Hara None; Shintaro Nakao Kowa Company. Ltd., Mitsubishi Tanabe Pharma Corporation, Alcon Japan, Ltd., Santen Pharmaceutical Co., Ltd., Machida Endoscope Co., Ltd., Wakamoto Pharmaceutical Co., Ltd., Bayer Yakuhin, Ltd., Senju Pharmaceutical Co., Ltd. Nippon Boehringer Ingelheim Co., Ltd., Chugai Pharmaceutical Co., Ltd., Hoya Corporation, and Novartis Pharma K.K., Code F (Financial Support)
  • Footnotes
    Support  JSPS KAKENHI Grant Numbers 21K20997, 22K16959
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 397. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      MAKO OKAMOTO, Yuichi Okumura, Takenori Inomata, Maria Miura, Keiichi Fujimoto, Kunihiko Hirosawa, Ken Nagino, yuki moroka, Fumihiro Hara, Shintaro Nakao; Cultured media from adipose derived stem cells promote corneal epithelial wound healing via increased cell proliferation and DNA metabolic process. Invest. Ophthalmol. Vis. Sci. 2024;65(7):397.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : This study aimed to determine the molecular mechanisms involved with using cultured media from adipose derived stem cells (CM-ADSCs) for corneal epithelial cell wound healing compared to platelet-rich plasma (PRP).

Methods : The efficacies of CM-ADSCs, PRP, and phosphate-buffered saline (PBS) were compared using an in vitro human corneal epithelial wound healing assay. The in vitro human corneal epithelial wounds were 70-µm wide for each well (96-well plate) containing cultured human corneal epithelial cells (HCECs). Following wounding, culture media were replaced with PBS, PRP, and CM-ADSCs, and diluted in corneal epithelial cell basal medium. Wound images were taken every 3h, and the area of the wound was calculated using the ImageJ software. RNA-sequencing analysis was performed on the collected HCECs after 12 hours post wound preparation.

Results : In the in vitro human corneal epithelial wound healing assay, the CM-ADSCs group significantly promoted wound healing compared to the PBS group and the PRP group (N = 6, P < 0.001, P = 0.020, respectively). The CM-ADSCs group (21.0±3.3 hours) had a significantly faster wound closure time compared to the PBS group (55.0±3.1 hours, P<0.001) and the PRP group (26.5±3.5 hours, P<0.001). Differentially expressed genes analysis showed that the expressions increased 1503 genes and decreased 1417 genes were identified in the CM-ADSCs group compared to PRP group. The Gene Ontology term enrichment analysis results revealed significantly enriched biological processes in increased DNA metabolic process and positive regulation of cell cycle process in CM-ADSCs group compared to the PRP group.

Conclusions : CM-ADSCs may promote wound healing of HCECs via increased cell proliferation and DNA metabolic process.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×